0001144204-12-020832.txt : 20120410
0001144204-12-020832.hdr.sgml : 20120410
20120410080136
ACCESSION NUMBER: 0001144204-12-020832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120405
FILED AS OF DATE: 20120410
DATE AS OF CHANGE: 20120410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FECZKO JOSEPH M
CENTRAL INDEX KEY: 0001319874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 12750737
MAIL ADDRESS:
STREET 1: PFIZER INC ATTN CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
v308866_4.xml
OWNERSHIP DOCUMENT
X0305
4
2012-04-05
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001319874
FECZKO JOSEPH M
C/O KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
NEW YORK
NY
10022
1
0
0
0
Common Stock
2012-04-05
4
P
0
20000
1.62
A
70000
D
Of the 70,000 shares, 18,333 are shares of restricted stock.
/s/ James F. Oliviero, III, Attorney-in-Fact
2012-04-09